Shared genetic factors may drive both osteoarthritis and cardiovascular disease, suggesting a common genetic basis that ...

Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

Zoetis' strategic divestiture of non-core assets and strong market position in companion animal drugs support a robust growth ...

A recent study found semaglutide – the drug known as Ozempic – can improve knee pain in people with obesity and ...

Knee cartilage is not designed for high stress loads. People who are overweight or obese are at a higher risk of developing osteoarthritis because of the extra stress on their knee joints, with many ...

Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.

The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...

Healing sore joints usually goes through three phases. The first is short-term improvements. This is mostly due to adding food compounds that are very anti-inflammatory. These include chondroitin ...

Genascence Corporation ("Genascence"), a clinical-stage biotechnology company revolutionizing the treatment of prevalent ...

The following is a summary of “Impact of Structural Severity on Outcomes in Knee Osteoarthritis: An Analysis of Data from ...

A new study shows that Ozempic may help ease arthritis knee pain in people with obesity. Here's what to know about the study and whether semaglutide can truly help reduce knee pain, according to ...